An Open-Label Feasibility Trial of Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Major Depressive Episodes

• Fujiwara Masaki

• Inagaki Masatoshi

• Higuchi Yuji

• Uchitomi Yosuke

• Terada Seishi

• Kodama Masafumi

• Kishi Yoshiki

• Yamada Norihito

抄録

Repetitive transcranial magnetic stimulation (rTMS) has been reported to be a new treatment option for treatment-resistant depression. In Japan, there has been limited research into its feasibility, efficacy, and tolerability. We have launched a trial of rTMS for treating medication-resistant major depressive disorder and bipolar depression. We are investigating low-frequency rTMS to the right dorsolateral prefrontal cortex and traditional high-frequency rTMS to the left dorsolateral prefrontal cortex, in 20 patients. The primary outcome of the study is the treatment completion rate. This study will provide new data on the usefulness of rTMS for treatment-resistant depression in Japan.

収録刊行物

• Acta Medica Okayama

  Acta Medica Okayama 70 (4), 307-311, 2016-08

  Okayama University Medical School

キーワード

• repetitive transcranial magnetic stimulation
• depression
• treatment resistance
• low frequency

詳細情報

• CRID: 1390853649749455744
• NII論文ID: 120005828922
• NII書誌ID: AA00508441
• ISSN: 0386300X
• DOI: 10.18926/amo/54510
• PubMed: 27549679
• Web Site: https://ousar.lib.okayama-u.ac.jp/54510
• 本文言語コード: en
• データソース種別:
  • JaLC
  • IRDB
  • PubMed
  • CiNii Articles